Search results for: 'real world drug'
- Related search terms
- Drug Discovery and Early Development Outsourcing Market
- drug 01 00 00 00
- drug discovery ad earth development outsourcing market
- drug discovery and east development outsourcing market
- drug discovery ad east development outsourcing market
-
11 Nov 2016  |  North America  |  Market Research
Global Orphan Drug Market
High Pricing and Undefined Reimbursement Policies will Limit the Sales of Orphan Drugs
The treatment of rare diseases requires the use of specialized drugs. Patient populations for rare diseases are most often quite small, consequently the products treating them earn the designation orphan drugs. These drugs must undergo the research, development, and clinical trials that all drugs do, yet the investment into the development is great...
$6,000.00 -
29 Nov 2021  |    |  Technology Research
Technology Developments in Synthetic Biology for Drug Discovery and Diagnostics
Advances in DNA, RNA, Protein Printing, and Automation Technologies to Drive Adoption of Synthetic Biology in the Next Three Years
The conventional drug discovery and diagnostics technologies are unable to cope up with the current disease management practices. To this end, researchers have explored possibilities beyond life sciences. Specifically, they have figured out that the use of engineering principles to biological systems can revolutionize the drug discovery and diagnos...
$4,950.00 -
29 Dec 2017  |  North America  |  Technology Research
Innovations in Transdermal Drug Delivery
Microneedle Technologies Creating Novel Opportunities in Transdermal Drug Delivery Industry
With the healthcare industry moving toward patient convenience and comfort, pharmaceutical and medical device companies are continuously researching for the most effective, side effect free, convenient route of drug delivery. Transdermal drug delivery is a painless method of delivering drug formulation. Transdermal route of drug administration has ...
$4,950.00 -
17 Oct 2025  |  Global  |  Technology Research
Recent Advances in Biologics and AI-based Drug Discovery and Development
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides actionable insights across new developments in prebiotics, immunology, oncology, cell and gene therapies, antibody therapies, and precision medicine approaches. The TOE also encompasses technology advances across the use of AI and ML in drug discovery a...
$950.00 -
16 Jun 2020  |  Global  |  Technology Research
Material Technologies Facilitating Targeted Drug Delivery
Nanomaterials are Gaining Research Focus for Targeted Drug Delivery
Targeted drug delivery is gaining traction owing toward significant demand for improvement in the drug delivery efficiency as well as the need to mitigate potential side-effects, which can occur due to drug accumulation. The concept of targeted drug delivery is not new, the technology started gaining pace with the advent of nanotechnology and bioco...
$4,950.00 -
01 Mar 2023  |  North America  |  Market Research
Climate-smart Cities: Growth Opportunities in the Global Real-time Monitoring of GHG Emissions Market
Disruptive Technologies for Digital Climate Monitoring Solutions to Accelerate Urban Transitions Towards a Net-zero Future
This study provides an analysis of the key cities around the world best positioned to implement smart emission monitoring solutions in the short, medium, and long terms. Cities account for 70% of global emissions and therefore play key roles in the transition towards a low-carbon economy. New technologies play an important role in this transition. ...
$4,950.00 -
01 Mar 2024  |  North America  |  Market Research
Global Orphan Drug Growth Opportunities
Reduced Exclusivity and Increased Competition will Drive Demand for More Efficient R&D and Digital Solutions
In this study, Frost & Sullivan s Transformational Health team provides critical insights into the global orphan drug (OD) industry and highlights growth opportunities, revenue, regulatory changes, and technology trends influencing growth. Approximately 5% of rare diseases (RDs) have received US FDA approval for a drug, while up to 15% of RDs have ...
$4,950.00 -
14 Aug 2023  |  Global  |  Frost Radar
Frost Radar™: Immersive Virtual World Platforms, 2023
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
Immersive virtual worlds offer a fully simulated digital experience similar to or very different from the real world. The visibility of immersive virtual worlds has increased in recent years due to investments from leading technology providers. Continued development and funding in the metaverse space from major tech firms have attracted more inte...
$4,950.00 -
23 Jan 2026  |  Global  |  Technology Research
Next-Generation Therapeutic Platforms: AI-Enabled Drug Discovery, Small molecules, Deep Proteomics, RNA Engineering, and Targeted Immunomodulation
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) delivers provides strategic insights into breakthrough innovations shaping the future of healthcare, life sciences, and precision therapeutics. It highlights advances in AI-enabled diagnostics, metabolic reprogramming, small molecules, deep proteomics, RNA disco...
$950.00 -
30 Mar 2016  |  Global  |  Technology Research
Next Generation Diabetes Therapy and Drug Delivery Technologies
Global Diabetes Epidemic Adds Urgency to R&D Initiatives, Inhalable and Transdermal Delivery on Upward Trajectory
Diabetes has exhibited dramatic increases during the past decade, registering a global prevalence of 9% among adults aged 18 years and older, and is projected to be the 7th-leading cause of death by 2030. The most popular treatment for type 1 diabetes mellitus (T1DM) is multiple daily insulin (MDI) injections. However, researchers globally are work...
$4,950.00